Security key
92539P101
- Type / Class
- Equity / COMMON STOCK
- Shares outstanding
- 85,151,237
- Total 13F shares
- 4,253,217
- Share change
- +903,809
- Total reported value
- $20,585,570
- Price per share
- $4.84
- Number of holders
- 1
- Value change
- +$4,374,435
- Number of buys
- 1
Report period
Q3 2024
Institutions
1
Top holders
3
92539P101 full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2024
Verve Therapeutics, Inc. SEC filings
Broader feeds
Reporting periods
Holder history for CUSIP 92539P101
Recent filing periods:
Top shareholders of 92539P101 - VERVE THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
7.8%
|
6,620,004
|
$32,305,619 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
3,349,408
|
$16,345,111 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.6%
|
507,360
|
$2,475,917 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.56%
|
474,500
|
$2,315,560 | — | 30 Jun 2024 |
Institutional Holders of VERVE THERAPEUTICS INC - COMMON STOCK as of Q3 2024
As of 30 Sep 2024,
VERVE THERAPEUTICS INC - COMMON STOCK was held by
1 institutional
shareholder
that filed Form 13F with the SEC.
Together, they reported ownership of
4,253,217 shares.
The largest 3 holders included
STATE STREET CORP, CITADEL ADVISORS LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
3
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
2
Q3 2024 holders
1
Holder diff
-1
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.